Immune-Mediated Hypophysitis: An Updated Review
Journal of Clinical Medicine · 27.04.2026 · 15 (9) · 3313
DOI: 10.3390/jcm15093313 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.04.2026. Verfasst von Pedro Iglesias. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Immune-mediated hypophysitis comprises a heterogeneous group of inflammatory pituitary disorders, including primary lymphocytic hypophysitis, immune checkpoint inhibitor (ICI)-induced hypophysitis, IgG4-related hypophysitis, and paraneoplastic autoimmune hypophysitis. Although these entities share immune-mediated mechanisms, they differ substantially in clinical presentation, imaging features, and therapeutic implications.
Methods
This narrative review synthesizes current evidence on the pathophysiology, clinical manifestations, radiological characteristics, diagnostic approach, and management of immune-mediated hypophysitis, with particular emphasis on etiological heterogeneity.
Results
Hypopituitarism—particularly ACTH deficiency—is the most frequent and clinically relevant manifestation, as secondary adrenal insufficiency may be life-threatening if not promptly recognized and treated. It is often accompanied by headache, arginine vasopressin deficiency, or mass effect depending on the subtype. Magnetic resonance imaging typically shows symmetrical pituitary enlargement and stalk thickening in inflammatory forms, although findings vary according to etiology and may be minimal in certain subtypes such as PD-1/PD-L1 inhibitor-associated hypophysitis. Distinct clinical phenotypes are observed across subtypes, particularly in ICI-induced hypophysitis and IgG4-related disease. Diagnosis relies on the integration of endocrine, radiological, and clinical features, supported by clinicoradiological scoring systems in selected cases. Management is primarily based on prompt hormone replacement, with selective use of glucocorticoids or immunosuppressive therapies depending on disease severity and underlying etiology.
Conclusions
Immune-mediated hypophysitis represents a clinically relevant and increasingly recognized spectrum of disorders requiring a multidisciplinary and etiology-specific approach. Early recognition is essential to prevent life-threatening endocrine complications. Advances in the understanding of immunopathogenic mechanisms and the identification of reliable biomarkers may enable earlier diagnosis and more personalized therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Nutrition, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.
- Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, 28222 Madrid, Spain.
ORCID-Profile: Pedro Iglesias
Zitieren
APA
Iglesias, P. (2026). Immune-Mediated Hypophysitis: An Updated Review. Journal of Clinical Medicine, 15(9), 3313. https://doi.org/10.3390/jcm15093313
Vancouver
Iglesias P. Immune-Mediated Hypophysitis: An Updated Review. Journal of Clinical Medicine. 2026;15(9):3313. doi:10.3390/jcm15093313
BibTeX
@article{Iglesias2026,
author = {Iglesias, Pedro},
title = {Immune-Mediated Hypophysitis: An Updated Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {9},
pages = {3313},
doi = {10.3390/jcm15093313}
}
EUVIMED